España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Perspective Therapeutics
CATX
AMEX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.85
0.01
0.35%
At close: -
$2.95
0.10
3.51%
After Hours: 6:54 PM EDT
Get Report
Comment
Perspective Therapeutics (CATX) Forecast
News
Earnings
Perspective Therapeutics (CATX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Perspective Therapeutics (AMEX:CATX) Stock
Perspective Therapeutics Stock (AMEX: CATX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 25, 2024
RBC Capital Maintains Outperform on Perspecti...
Benzinga Newsdesk
B of A Securities Downgrades Perspective Ther...
Benzinga Newsdesk
Thursday, November 21, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Perspective Therapeutics shares are trading l...
Benzinga Newsdesk
Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings
Avi Kapoor
Perspective Therapeutics Plans To Pursue Dose...
Benzinga Newsdesk
Perspective Therapeutics Announced Initial Re...
Benzinga Newsdesk
Friday, November 15, 2024
Perspective Therapeutics To Discuss Data On [...
Benzinga Newsdesk
Tuesday, November 12, 2024
Perspective Therapeutics Q3 2024 GAAP EPS $(0...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Wednesday, October 30, 2024
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Vandana Singh
Thursday, October 24, 2024
Wedbush Reiterates Outperform on Perspective ...
Benzinga Newsdesk
UBS Initiates Coverage On Perspective Therape...
Benzinga Newsdesk
Wednesday, October 23, 2024
Perspective Therapeutics Announced Six Update...
Benzinga Newsdesk
Wednesday, October 16, 2024
Perspective Therapeutics Announced The First ...
Benzinga Newsdesk
Friday, October 11, 2024
S&P 500 Moves Higher; BlackRock Reports Upbeat Results
Avi Kapoor
Oppenheimer Reiterates Outperform on Perspect...
Benzinga Newsdesk
Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings
Avi Kapoor
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
Vandana Singh
Dow Surges 150 Points; JPMorgan Posts Upbeat Earnings
Avi Kapoor
Perspective Therapeutics To Advance Developme...
Benzinga Newsdesk
Tuesday, October 01, 2024
Wedbush Initiates Coverage On Perspective The...
Benzinga Newsdesk
Wednesday, September 25, 2024
Truist Securities Initiates Coverage On Persp...
Benzinga Newsdesk
Tuesday, September 10, 2024
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Monday, September 09, 2024
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Friday, September 06, 2024
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Thursday, September 05, 2024
Perspective Therapeutics Says FDA Granted Fas...
Benzinga Newsdesk
Tuesday, September 03, 2024
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Friday, August 16, 2024
RBC Capital Maintains Outperform on Perspecti...
Benzinga Newsdesk
Tuesday, August 13, 2024
Oppenheimer Maintains Outperform on Perspecti...
Benzinga Newsdesk
Monday, August 12, 2024
Perspective Therapeutics shares are trading l...
Benzinga Newsdesk
UPDATE: Perspective Therapeutics Q2 EPS $(0.1...
Benzinga Newsdesk
Thursday, July 25, 2024
B of A Securities Initiates Coverage On Persp...
Benzinga Newsdesk
Tuesday, June 25, 2024
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Thursday, June 20, 2024
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Tuesday, June 18, 2024
Oppenheimer Reiterates Outperform on Perspect...
Benzinga Newsdesk
Oppenheimer Reiterates Outperform on Perspect...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Pe...
Benzinga Newsdesk
Friday, June 14, 2024
RBC Capital Reiterates Outperform on Perspect...
Benzinga Newsdesk
$1.8M Bet On This Health Care Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Avi Kapoor
Tuesday, June 11, 2024
Perspective Therapeutics Announces 1-For-10 R...
Benzinga Newsdesk
Monday, June 10, 2024
Perspective Therapeutics Announces Six Update...
Benzinga Newsdesk
Tuesday, June 04, 2024
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor
Friday, May 24, 2024
Perspective Therapeutics Prices $80M Underwri...
Benzinga Newsdesk
Thursday, May 16, 2024
Jones Trading Maintains Buy on Perspective Th...
Benzinga Newsdesk
Wednesday, May 15, 2024
Perspective Therapeutics Q1 2024 GAAP EPS $(0...
Benzinga Newsdesk
Tuesday, May 14, 2024
RBC Capital Initiates Coverage On Perspective...
Benzinga Newsdesk
Thursday, May 09, 2024
Cantor Fitzgerald Initiates Coverage On Persp...
Benzinga Newsdesk
Tuesday, April 30, 2024
FDA Selects Perspective Therapeutics To Parti...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch